HYG | NUHY | HYG / NUHY | |
Gain YTD | 8.094 | 7.545 | 107% |
Net Assets | 15B | 89.7M | 16,722% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 31.00 | 44.00 | 70% |
Yield | 5.73 | 6.71 | 85% |
Fund Existence | 18 years | 5 years | - |
HYG | NUHY | |
---|---|---|
RSI ODDS (%) | 2 days ago50% | 2 days ago57% |
Stochastic ODDS (%) | 2 days ago58% | 2 days ago53% |
Momentum ODDS (%) | 2 days ago53% | 2 days ago51% |
MACD ODDS (%) | 2 days ago64% | 2 days ago46% |
TrendWeek ODDS (%) | 2 days ago56% | 2 days ago56% |
TrendMonth ODDS (%) | 2 days ago52% | 2 days ago53% |
Advances ODDS (%) | 4 days ago58% | 4 days ago61% |
Declines ODDS (%) | 8 days ago57% | 8 days ago49% |
BollingerBands ODDS (%) | 2 days ago68% | 2 days ago57% |
Aroon ODDS (%) | 2 days ago53% | 2 days ago52% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WQAIX | 12.54 | 0.17 | +1.37% |
Westwood Quality AllCap Institutional | |||
RMBNX | 46.77 | 0.59 | +1.28% |
RMB Mendon Financial Services C | |||
EQNTX | 22.64 | 0.21 | +0.94% |
MFS Equity Income R3 | |||
PHLCX | 18.10 | 0.11 | +0.61% |
PGIM Jennison Health Sciences C | |||
JEMWX | 31.24 | -0.06 | -0.19% |
JPMorgan Emerging Markets Equity R6 |
A.I.dvisor tells us that HYG and SM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYG and SM's prices will move in lockstep.